Formation of therapeutic phage cocktail and endolysin to highly multi-drug resistant Acinetobacter baumannii: in vitro and in vivo study

سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 155

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-21-11_002

تاریخ نمایه سازی: 27 مهر 1400

چکیده مقاله:

Objective(s): Phage therapy is a potential alternative treatment for infections caused by Acinetobacter baumannii, a significant nosocomial pathogen, which has evolved resistance to almost all conventional antimicrobial drugs in poor hygiene and conflicts areas such as Iraq. Materials and Methods: Bacteriophages were isolated to highly resistant isolates of A. baumannii to form therapeutic phage cocktail, and to extract and evaluate native endolysin activity. Bacterial samples were collected in Al-Imamein Al-kadhimein Medical City Hospital. Phages were isolated from different regions in Baghdad city including (soil, sewage, irrigation channels). Phage endolysin was extracted from highly lytic phages that produced halo-like appearance around inhibition zone. Results: Up to ۲۳ isolates of extensive- and pan- drug resistant (XDR, PDR) A. baumannii were isolated from patients with various infections, and ۱۳۶ lytic phages specific to A. baumannii were isolated. Each bacterial isolate was sensitive to at least one lytic phage. Accordingly, a phage cocktail was formulated which remarkably minimized bacterial resistance to lysis by phages when compared to individual lytic phages. And, the phage cocktail succeeded in treating and saving life of all bacteremic mice with A. baumannii versus the non-treated group. In addition, the endolysin native activity to A. baumannii was evaluated in this study; endolysin revealed a potent antibacterial activity (> ۱ log) reduction of bacterial density in just one hour of endolysin treatment. Conclusion: The phage therapy assessed in this study showed an ability to efficiently solve the problems of “superbug” bacteria by lysing effectively most XDR, PDR bacteria in vitro and in vivo. And, phage cocktail was shown to be superior over single-phage preparations in treating A. baumannii with much less resistance rate to therapeutic phages. Furthermore, intrinsic activity of native endolysin revealed promising results to tackling superbug pathogens.

نویسندگان

Hayder Nsaif Jasim

College of Medicine, AL-Nahrain University, Medical Microbiology Department, Baghdad, Iraq

Rand Riadh Hafidh

College of Medicine, Baghdad University, Department of Microbiology, Baghdad, Iraq

Ahmed Sahib Abdulamir

College of Medicine, AL-Nahrain University, Medical Microbiology Department, Baghdad, Iraq

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Cantas L, Shah S, Cavaco L, Manaia C, Walsh F, ...
  • World Health Organization. Antimicrobial resistance: global report on surveillance. World ...
  • Murray CK, Yun HC, Griffith ME, Thompson B, Crouch HK, ...
  • Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, ...
  • O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. ...
  • Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. Phage treatment ...
  • Hendrix RW, Smith MC, Burns RN, Ford ME, Hatfull GF. ...
  • Clokie MR, Millard AD, Letarov AV, Heaphy S. Phages in ...
  • Flores CO, Meyer JR, Valverde S, Farr L, Weitz JS. ...
  • Örmälä AM, Jalasvuori M. Phage therapy: should bacterial resistance to ...
  • Mattila S, Ruotsalainen P, Jalasvuori M. On-demand isolation of bacteriophages ...
  • Sulakvelidze A, Alavidze Z, Morris JG. Bacteriophage therapy. Antimicrob Agents ...
  • Chan BK, Abedon ST. Phage therapy pharmacology: phage cocktails. Adv ...
  • Falagas ME, Vardakas KZ, Kapaskelis A, Triarides NA, Roussos NS. ...
  • Schmelcher M, Donovan DM, Loessner MJ. Bacteriophage endolysins as novel ...
  • Briers Y, Walmagh M, Lavigne R. Use of bacteriophage endolysin ...
  • Briers Y, Walmagh M, Van Puyenbroeck V, Cornelissen A, Cenens ...
  • Merril CR, Scholl D, Adhya SL. The prospect for bacteriophage ...
  • WHO (World Health Organization). ۲۰۰۳. Basic laboratory procedures in clinical ...
  • Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility ...
  • Jassim SA, Abdualamir AS and Abu baker F. Methods for ...
  • Biswas B, Adhya S, Washart P, Paul B, Trostel AN, ...
  • Simmons M, Donovan DM, Siragusa GR, Seal BS. Recombinant expression ...
  • Mshachal MA, Abdulrahman TR, Khudair MS, Hassan JS. Molecular detection ...
  • Al Marjani M, Al-Ammar M, Kadhem E. Occurrence of ESBL ...
  • Qureshi ZA, Hittle LE, O'hara JA, Rivera JI, Syed A, ...
  • Pelletier MR, Casella LG, Jones JW, Adams MD, Zurawski DV, ...
  • Arroyo LA, Herrera CM, Fernandez L, Hankins JV, Trent MS, ...
  • Jain R, Danziger LH. Multidrug-resistant Acinetobacter infections: an emerging challenge ...
  • Rodríguez-Martínez JM, Nordmann P, Ronco E, Poirel L. Extended-spectrum cephalosporinase ...
  • Bragg R, van der Westhuizen W, Lee JY, Coetsee E, ...
  • Kusradze I, Karumidze N, Rigvava S, Dvalidze T, Katsitadze M, ...
  • Regeimbal JM, Jacobs AC, Corey BW, Henry MS, Thompson MG, ...
  • Merabishvili M, Vandenheuvel D, Kropinski AM, Mast J, De Vos ...
  • Łobocka M, Hejnowicz MS, Gagała U, Weber-Dabrowska B, Wegrzyn G, ...
  • Jassim S, Abdulamir A, Abu Bakar F. Phage-based limulus amoebocyte ...
  • Kelly D, McAuliffe O, O’Mahony J, Coffey A. Development of ...
  • Benjamin K Chan, Stephen T Abedon, Catherine Loc-Carrillo Future Microbiol ...
  • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of ...
  • Lai MJ, Lin NT, Hu A, Soo PC, Chen LK, ...
  • Briers Y, Volckaert G, Cornelissen A, Lagaert S, Michiels CW, ...
  • Miroshnikov K, Faizullina N, Sykilinda N, Mesyanzhinov V. Properties of ...
  • Paradis-Bleau C, Cloutier I, Lemieux L, Sanschagrin F, Laroche J, ...
  • Junn HJ, Youn J, Suh KH, Lee SS. Cloning and ...
  • Mikoulinskaia GV, Odinokova IV, Zimin AA, Lysanskaya VY, Feofanov SA, ...
  • Schmelcher M, Shabarova T, Eugster MR, Eichenseher F, Tchang VS, ...
  • Loessner MJ, Kramer K, Ebel F, Scherer S. C‐terminal domains ...
  • Lood R, Winer BY, Pelzek AJ, Diez-Martinez R, Thandar M, ...
  • Hibbing ME, Fuqua C, Parsek MR, Peterson SB. Bacterial competition: ...
  • Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, ...
  • Debarbieux L, Leduc D, Maura D, Morello E, Criscuolo A, ...
  • Pires DP, Vilas Boas D, Sillankorva S, Azeredo J. Phage ...
  • McCallin S, Alam Sarker S, Barretto C, Sultana S, Berger ...
  • Reyes A, Semenkovich NP, Whiteson K, Rohwer F, Gordon JI. ...
  • Skurnik M, Pajunen M, Kiljunen S. Biotechnological challenges of phage ...
  • Merril CR, Scholl D, Adhya S. Phage Therapy. In Calendar ...
  • نمایش کامل مراجع